Fibroblast growth factor-2-induced cardioprotection against myocardial infarction occurs via the interplay between nitric oxide, protein kinase signaling, and ATP-sensitive potassium channels

Janet R. Manning, Gregory Carpenter, Darius R. Porter, Stacey L. House, Daniel A. Pietras, Thomas C Doetschman, Jo El J Schultz

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Fibroblast growth factor-2 (FGF2) protects the heart from ischemia-reperfusion (I-R) injury via a vast network of protein kinases. In the heart, downstream effectors of these FGF2-triggered signals have not yet been identified. It is hypothesized that nitric oxide (NO) signaling and ATP-sensitive potassium (K ATP) channel activity are key effectors of protein kinases activated by FGF2-mediated cardioprotection. Hearts with a cardiac-specific overexpression of FGF2 (FGF2 Tg) were subjected to I-R injury in the absence or the presence of selective inhibitors of NO synthase (NOS) isoforms or sarcolemmal (sarcK ATP) and mitochondrial (mitoK ATP) K ATP channels. Multiple NOS isoforms are necessary for FGF2-mediated cardioprotection, and nitrite levels are significantly reduced in FGF2 Tg hearts upon inhibition of protein kinase C or mitogen-activated protein kinases. Likewise, sarcK ATP and mitoK ATP channels are important for cardioprotection elicited by endogenous FGF2. These findings suggest that FGF2-induced cardioprotection occurs via protein kinase-NOS pathways as well as K ATP channel activity.

Original languageEnglish (US)
Pages (from-to)124-139
Number of pages16
JournalGrowth Factors
Volume30
Issue number2
DOIs
StatePublished - Apr 2012
Externally publishedYes

Fingerprint

KATP Channels
Fibroblast Growth Factor 2
Protein Kinases
Nitric Oxide
Myocardial Infarction
Adenosine Triphosphate
Nitric Oxide Synthase
Reperfusion Injury
Protein Isoforms
Adenosinetriphosphate
Nitrites
Mitogen-Activated Protein Kinases
Protein Kinase C
Potassium

Keywords

  • extracellular signal regulated kinase (ERK)
  • Growth factor
  • ischemia-reperfusion
  • nitric oxide synthase
  • p38
  • PKC
  • transgenic mouse

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Endocrinology
  • Cell Biology

Cite this

Fibroblast growth factor-2-induced cardioprotection against myocardial infarction occurs via the interplay between nitric oxide, protein kinase signaling, and ATP-sensitive potassium channels. / Manning, Janet R.; Carpenter, Gregory; Porter, Darius R.; House, Stacey L.; Pietras, Daniel A.; Doetschman, Thomas C; Schultz, Jo El J.

In: Growth Factors, Vol. 30, No. 2, 04.2012, p. 124-139.

Research output: Contribution to journalArticle

Manning, Janet R. ; Carpenter, Gregory ; Porter, Darius R. ; House, Stacey L. ; Pietras, Daniel A. ; Doetschman, Thomas C ; Schultz, Jo El J. / Fibroblast growth factor-2-induced cardioprotection against myocardial infarction occurs via the interplay between nitric oxide, protein kinase signaling, and ATP-sensitive potassium channels. In: Growth Factors. 2012 ; Vol. 30, No. 2. pp. 124-139.
@article{291a36cb51334f8fa6322f6c63fa3ea0,
title = "Fibroblast growth factor-2-induced cardioprotection against myocardial infarction occurs via the interplay between nitric oxide, protein kinase signaling, and ATP-sensitive potassium channels",
abstract = "Fibroblast growth factor-2 (FGF2) protects the heart from ischemia-reperfusion (I-R) injury via a vast network of protein kinases. In the heart, downstream effectors of these FGF2-triggered signals have not yet been identified. It is hypothesized that nitric oxide (NO) signaling and ATP-sensitive potassium (K ATP) channel activity are key effectors of protein kinases activated by FGF2-mediated cardioprotection. Hearts with a cardiac-specific overexpression of FGF2 (FGF2 Tg) were subjected to I-R injury in the absence or the presence of selective inhibitors of NO synthase (NOS) isoforms or sarcolemmal (sarcK ATP) and mitochondrial (mitoK ATP) K ATP channels. Multiple NOS isoforms are necessary for FGF2-mediated cardioprotection, and nitrite levels are significantly reduced in FGF2 Tg hearts upon inhibition of protein kinase C or mitogen-activated protein kinases. Likewise, sarcK ATP and mitoK ATP channels are important for cardioprotection elicited by endogenous FGF2. These findings suggest that FGF2-induced cardioprotection occurs via protein kinase-NOS pathways as well as K ATP channel activity.",
keywords = "extracellular signal regulated kinase (ERK), Growth factor, ischemia-reperfusion, nitric oxide synthase, p38, PKC, transgenic mouse",
author = "Manning, {Janet R.} and Gregory Carpenter and Porter, {Darius R.} and House, {Stacey L.} and Pietras, {Daniel A.} and Doetschman, {Thomas C} and Schultz, {Jo El J}",
year = "2012",
month = "4",
doi = "10.3109/08977194.2012.656759",
language = "English (US)",
volume = "30",
pages = "124--139",
journal = "Growth Factors",
issn = "0897-7194",
publisher = "Informa Healthcare",
number = "2",

}

TY - JOUR

T1 - Fibroblast growth factor-2-induced cardioprotection against myocardial infarction occurs via the interplay between nitric oxide, protein kinase signaling, and ATP-sensitive potassium channels

AU - Manning, Janet R.

AU - Carpenter, Gregory

AU - Porter, Darius R.

AU - House, Stacey L.

AU - Pietras, Daniel A.

AU - Doetschman, Thomas C

AU - Schultz, Jo El J

PY - 2012/4

Y1 - 2012/4

N2 - Fibroblast growth factor-2 (FGF2) protects the heart from ischemia-reperfusion (I-R) injury via a vast network of protein kinases. In the heart, downstream effectors of these FGF2-triggered signals have not yet been identified. It is hypothesized that nitric oxide (NO) signaling and ATP-sensitive potassium (K ATP) channel activity are key effectors of protein kinases activated by FGF2-mediated cardioprotection. Hearts with a cardiac-specific overexpression of FGF2 (FGF2 Tg) were subjected to I-R injury in the absence or the presence of selective inhibitors of NO synthase (NOS) isoforms or sarcolemmal (sarcK ATP) and mitochondrial (mitoK ATP) K ATP channels. Multiple NOS isoforms are necessary for FGF2-mediated cardioprotection, and nitrite levels are significantly reduced in FGF2 Tg hearts upon inhibition of protein kinase C or mitogen-activated protein kinases. Likewise, sarcK ATP and mitoK ATP channels are important for cardioprotection elicited by endogenous FGF2. These findings suggest that FGF2-induced cardioprotection occurs via protein kinase-NOS pathways as well as K ATP channel activity.

AB - Fibroblast growth factor-2 (FGF2) protects the heart from ischemia-reperfusion (I-R) injury via a vast network of protein kinases. In the heart, downstream effectors of these FGF2-triggered signals have not yet been identified. It is hypothesized that nitric oxide (NO) signaling and ATP-sensitive potassium (K ATP) channel activity are key effectors of protein kinases activated by FGF2-mediated cardioprotection. Hearts with a cardiac-specific overexpression of FGF2 (FGF2 Tg) were subjected to I-R injury in the absence or the presence of selective inhibitors of NO synthase (NOS) isoforms or sarcolemmal (sarcK ATP) and mitochondrial (mitoK ATP) K ATP channels. Multiple NOS isoforms are necessary for FGF2-mediated cardioprotection, and nitrite levels are significantly reduced in FGF2 Tg hearts upon inhibition of protein kinase C or mitogen-activated protein kinases. Likewise, sarcK ATP and mitoK ATP channels are important for cardioprotection elicited by endogenous FGF2. These findings suggest that FGF2-induced cardioprotection occurs via protein kinase-NOS pathways as well as K ATP channel activity.

KW - extracellular signal regulated kinase (ERK)

KW - Growth factor

KW - ischemia-reperfusion

KW - nitric oxide synthase

KW - p38

KW - PKC

KW - transgenic mouse

UR - http://www.scopus.com/inward/record.url?scp=84858961437&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84858961437&partnerID=8YFLogxK

U2 - 10.3109/08977194.2012.656759

DO - 10.3109/08977194.2012.656759

M3 - Article

VL - 30

SP - 124

EP - 139

JO - Growth Factors

JF - Growth Factors

SN - 0897-7194

IS - 2

ER -